UNSPSC 41141830: Total lipids

In this classification, this entry connotes a substrate made of Total lipids that is used in clinical chemistry testing.

UNSPSC 41141830 Total lipids, a Commodity code, describes laboratory reagents, consumables, and analytical standards that state and local health departments and universities procure for diagnostic testing, pathogen surveillance, and compliance verification. Recent opportunities show state health agencies sourcing molecular diagnostics kits for wastewater surveillance and respiratory pathogen detection, culture media for foodborne pathogen identification, solid-phase extraction disks for drinking water analysis under EPA methods, gas chromatography columns and chemical standards for Safe Drinking Water Act compliance testing, and whole-genome sequencing reagent bundles for SARS-CoV-2 and foodborne illness outbreak investigation. The Texas Health and Human Services Commission (HHSC) on behalf of the Department of State Health Services (DSHS) is the dominant issuing body in the dataset, posting multiple IFBs for molecular diagnostics and analytical standards; the Mississippi State Department of Health (MSDH) and the University of Texas Health Science Center at San Antonio (UTHSA) also appear as repeat buyers. Procurement vehicles include competitive sealed IFBs, sole-source notices, and RFPs; sole-source designations reflect locked-in instrument compatibility (Clear Labs and Illumina sequencer systems) and direct-vendor relationships in the clinical diagnostics supply chain.

Texas dominates recent activity, with HHSC/DSHS posting at least five separate IFBs since February 2026 (HHS0016987 for Atlantic ReadyDisk HC-C18 solid-phase extraction disks, due February 12, 2026; HHS0016980 for a Clear Dx sequencer instrument, due February 19, 2026; HHS0017271 for gas chromatography columns and chemical standards, due May 12, 2026; HHS0017287 for Atlantic ReadyDisk HC-C18 units, due May 13, 2026; and HHS0017132 for culture media, due June 2, 2026). Mississippi MSDH issued sole-source procurements for Clear Labs reagents ($226,072.00 total, objection deadline May 14, 2026) and Illumina sequencer reagents ($393,667.98 total, objection deadline May 14, 2026). California posted two RFBs for diagnostic reagents (MyCodeDR Reagents, due April 29, 2026; Cerilliant Certified spiking solutions, due April 13, 2026). Philadelphia issued a micro purchase RFQ for Clean Thru extraction columns ($43,000 ceiling, due May 30, 2026). UTHSA issued an RFP for a comprehensive biotech research and clinical diagnostics equipment catalog (due June 4, 2026, 8,768 line items ordered in prior year). Historical spending ranges from $25,050 to $393,667.98; most Texas procurements show FY 2025–2026 guidance between $40,000 and $90,000. All opportunities require firm, fixed pricing in USD; Texas procurements mandate HHS Solicitation Affirmations certifications and Buy Texas preferences; California opportunities include CBE (Certified Business Enterprise) set-aside considerations.